Aberforth Smaller Companies Trust (ASL) Share Price, News & Analysis

Company Overview

Aberforth Smaller Companies Trust Plc is a closed-ended equity mutual fund launched and managed by Aberforth Partners LLP. The fund invests in public equity markets of the United Kingdom. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in value stocks of small-cap companies. It employs fundamental analysis with both bottom-up and top-down stock picking approaches with the focus on factors like businesses financial statements and assessment of their market positions to create its portfolio. The fund benchmarks the performance of its portfolio against the Numis Smaller Companies Index (Excluding Investment Companies). Aberforth Smaller Companies Trust Plc was formed on December 10, 1990 and is domiciled in the United Kingdom.

Key Stats

• Today's Range: 1,525.60 to 1,538
• 50-Day Range: 1,360 to 1,555.88
• 52-Week Range: 1,162 to 1,690
• Volume: 43,602 shs
• Average Volume: 169,528 shs
• Market Capitalization: £1.27 billion
• P/E Ratio: 5.01
• Dividend Yield: 2.75%
• Price Target: N/A
• Consensus Rating: N/A

ASL Stock Analysis - Frequently Asked Questions

How have ASL shares performed this year?

Aberforth Smaller Companies Trust's stock was trading at GBX 1,470 at the beginning of 2025. Since then, ASL stock has increased by 3.8% and is now trading at GBX 1,526.

How do I buy shares of Aberforth Smaller Companies Trust?

Shares of ASL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Aberforth Smaller Companies Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aberforth Smaller Companies Trust investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:ASL
• CIK: N/A
• Web: www.aberforth.co.uk
• Phone: 44 13 1220 0733
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX 304.31
• Trailing P/E Ratio: 5.01
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £255.01 million
• Net Margins: 112.81%
• Pretax Margin: N/A
• Return on Equity: 18.22%
• Return on Assets: 11.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: 4.86

Sales & Book Value

• Annual Sales: £226.05 million
• Price / Sales: 5.63
• Cash Flow: GBX 1.17 per share
• Price / Cash Flow: 1,306.00
• Book Value: GBX 1,659.67 per share
• Price / Book: 0.92

Miscellaneous

• Outstanding Shares: 83,468,277
• Free Float: N/A
• Market Cap: £1.27 billion
• Optionable: Not Optionable
• Beta: 1.38